Fri, January 25, 2013
Thu, January 24, 2013
Wed, January 23, 2013
Tue, January 22, 2013
Mon, January 21, 2013
Fri, January 18, 2013
Thu, January 17, 2013
Wed, January 16, 2013
Tue, January 15, 2013
Mon, January 14, 2013
Fri, January 11, 2013
Thu, January 10, 2013
Wed, January 9, 2013
Tue, January 8, 2013
[ Tue, Jan 08th 2013 ] - Market Wire
Cambridge Heart Provides Update
Mon, January 7, 2013
Sun, January 6, 2013
Fri, January 4, 2013
Thu, January 3, 2013
Wed, January 2, 2013
Mon, December 31, 2012
Fri, December 28, 2012
Thu, December 27, 2012
Wed, December 26, 2012
[ Wed, Dec 26th 2012 ] - Market Wire
30 p.m. ET
Mon, December 24, 2012
Fri, December 21, 2012

January 30, 2013


//health-fitness.news-articles.net/content/2013/01/09/january-30-2013.html
Published in Health and Fitness on Wednesday, January 9th 2013 at 13:15 GMT, Last Modified on 2013-01-09 13:29:38 by Market Wire   Print publication without navigation


Haemonetics Sets Date for Third Quarter Fiscal Year 2013 Earnings Release: January... -- BRAINTREE, Mass., Jan. 9, 2013 /PRNewswire/ --

BRAINTREE, Mass., Jan. 9, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: [ HAE ]) will announce its earnings for the third quarter of its fiscal year 2013 on January 30, 2013 in a pre-market press release.  The Company will hold a webcast to discuss and answer questions about the press release at 8:00 am (EST) on January 30, 2013.

(Logo: [ http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ] )

Webcast Link: [ http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=72118&eventID=4888434 ]

Webcast replay will be available from January 30, 2013 after 11:00 am (EST) until February 6, 2013.

Haemonetics (NYSE: [ HAE ]) is a global healthcare company dedicated to providing innovative blood management solutions for our customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at [ http://www.haemonetics.com ].

CONTACT: 
Gerry Gould , VP-Investor Relations  
Tel. (781) 356-9402  
[ gerry.gould@haemonetics.com ]  
Alt. (781) 356-9613  

SOURCE Haemonetics Corporation



RELATED LINKS
[ http://www.haemonetics.com ]

Publication Contributing Sources